Navigation Links
New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance
Date:6/12/2009

Faster reporting aids physicians in identifying HIV mutations that can inhibit effectiveness of newest class of antiretroviral therapy

MADISON, N.J., June 12 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced the availability of a new laboratory developed test designed to help physicians determine whether a patient with a history of HIV drug resistance will respond to the latest class of HIV antiretroviral therapies. The HIV-1 Coreceptor Tropism Test, which reports results in approximately half the time of the nearest competing test, provides physicians with timely information so they may more quickly determine or change therapy based on how the HIV virus infects cells in the individual patient.

"Diagnostic testing is at the center of personalized medicine, providing genetic insights necessary to understand which medicines are most likely to produce a favorable health outcome for the individual patient," said Jon R. Cohen, M.D., senior vice president and chief medical officer, Quest Diagnostics. "Our new HIV tropism test will advance personalized medicine for HIV by helping physicians identify suitable patients for a particular therapy and ensure those who are not suitable do not lose precious treatment time potentially better spent on a different drug."

HIV coreceptor tropism refers to the preference of strains of HIV to bind to, activate and infect cells, promoting disease progression, based on the type of coreceptor on the cell's surface. The newest class of antiretroviral drugs, called entry inhibitors, targets the tropism process involving one or both coreceptors, CCR5 or CXCR4, of CD4 cells, which help the immune system fight infection. HIV-1 viral particles that use the CCR5 coreceptor to infect
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
2. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
3. Quest Diagnostics to Speak at the 2007 UBS Global Life Sciences Conference
4. VioQuest Pharmaceuticals to Present at BIO InvestorForum in San Francisco
5. Quest Diagnostics Joins National ePrescribing Patient Safety Initiative (NEPSI)
6. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
7. VioQuest Pharmaceuticals to Present at the Paramount BioSciences Healthcare Conference
8. Sinovac Requests Extension for Annual Shareholders Meeting
9. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
10. AmSurg Selects SciQuest Eprocurement Solution to Automate Purchasing of Medical Goods and Services
11. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 24, 2014   BioLife Solutions , Inc. ... and marketer of proprietary clinical grade hypothermic storage ... precision thermal shipping products for cells and tissues  ... hold its 2015 Annual Meeting of Stockholders on May ... expected date for the Annual Meeting represents a change ...
(Date:12/24/2014)... 23, 2014 On Friday, December ... 83, the Omnibus and Continuing Resolution Appropriations Act ... hydrocephalus a condition eligible to receive funding through ... by the Department of Defense (DoD). The Hydrocephalus ... on Capitol Hill, is celebrating this victory for ...
(Date:12/24/2014)... Diego, CA (PRWEB) December 23, 2014 ... where their Twitter followers can submit their #HolidayInTheLab ... themselves and their lab mates. , For those struggling ... lab mates, the Pipette.com Holiday in the Lab Contest ... Pipette.com Twitter followers to send pictures of ...
(Date:12/24/2014)... Dec. 23, 2014  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... filed a Clinical Trial Application (CTA) with the ... Agency (MHRA) seeking regulatory approval to initiate clinical trials ... Citrate. Contingent on the Company receiving CTA ... I trial to assess the safety, tolerability and dose ...
Breaking Biology Technology:BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3
... Sciences, Inc. announced today that it has become an ... to Life Care Centers of America (LCCA). ... improves quality of life by accelerating the healing process ...   Ease of use, portability, safety and ...
... NES-ZIONA, Israel, Sept. 27 ... ... var ... by longUrl, so we need to grab the first one. for (var r in data.results) { first_result ...
... SYDNEY, Sept. 27 Clinical Genomics Pty. Ltd ... Research (Sydney, Australia) today announced that they have ... novel biomarkers discovered by scientists at the Garvan ... Genomics obtains worldwide exclusive rights to the Garvan,s ...
Cached Biology Technology:ReGear Life Sciences Partners with Life Care Centers of America 2PROLOR Biotech's Longer-Acting Human Growth Hormone Data Selected for Presentation at 5th International Congress Of The Growth Hormone Research Society and IGF Society 2PROLOR Biotech's Longer-Acting Human Growth Hormone Data Selected for Presentation at 5th International Congress Of The Growth Hormone Research Society and IGF Society 3PROLOR Biotech's Longer-Acting Human Growth Hormone Data Selected for Presentation at 5th International Congress Of The Growth Hormone Research Society and IGF Society 4PROLOR Biotech's Longer-Acting Human Growth Hormone Data Selected for Presentation at 5th International Congress Of The Growth Hormone Research Society and IGF Society 5PROLOR Biotech's Longer-Acting Human Growth Hormone Data Selected for Presentation at 5th International Congress Of The Growth Hormone Research Society and IGF Society 6PROLOR Biotech's Longer-Acting Human Growth Hormone Data Selected for Presentation at 5th International Congress Of The Growth Hormone Research Society and IGF Society 7PROLOR Biotech's Longer-Acting Human Growth Hormone Data Selected for Presentation at 5th International Congress Of The Growth Hormone Research Society and IGF Society 8PROLOR Biotech's Longer-Acting Human Growth Hormone Data Selected for Presentation at 5th International Congress Of The Growth Hormone Research Society and IGF Society 9Clinical Genomics Pty Ltd and The Garvan Institute of Medical Research Enter into Licensing Agreement 2
(Date:12/3/2014)... , Dec. 2, 2014   Marvin ... deployed, innovative test solutions for military, aerospace, and ... version of its successful TS-900 PXI semiconductor ... and features of high-end systems to customers at ... value compared to traditional ATE. ...
(Date:11/21/2014)... -- Earlier this year Donald Spector , Chairman of ... the most prolific inventors in the world, got a ... to third party agencies. Spector envisioned this technology even ... earliest known patents in this area. Now major technology ... care, elder care and hospital applications. This technology has ...
(Date:11/21/2014)... JOSE, Calif. , Nov. 20, 2014   ... global leader in microcontroller (MCU) and touch technology solutions, ... digital temperature sensors with the widest V cc ... delivers higher temperature accuracy and faster I 2 C ... registers and serial EEPROM memory making them ideal for ...
Breaking Biology News(10 mins):Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4
... University researchers discover that green tea leaves not only ... tea, but they make an excellent antibacterial coating, too. ... and cacao beans, they found. It,s the powerful and ... are naturally occurring molecules found in plants whose functions ...
... features of humanity is our capacity for empathy the ... of Virginia study strongly suggests that we are hardwired to ... us friends, spouses, lovers with our very selves., ... Coan, a psychology professor in U.Va.,s College of Arts & ...
... the journal Biodiversity Conservation , the researchers also ... for promoting low-profile species that are either endangered or ... is limited to social, intelligent animals, such as chimpanzees, ... would imply that other species are not worthy of ...
Cached Biology News:Sticking power of plant polyphenols used in new coatings 2Sticking power of plant polyphenols used in new coatings 3Human brains are hardwired for empathy, friendship, study shows 2Relating animals to humans could help conservation projects 2
Mycoplasma and virus tested...
Mycoplasma and virus tested...
... MagicMark and MagicMark XP Western Protein ... and convenient protein molecular weight estimation ... protein contains an IgG binding site, ... antibody-conjugate reagents used to detect your ...
Edited by Benjamin Lewin (1997) • This book gives an integrated account of the structure and function of genes in both prokaryotic organisms and is thoroughly up to date with the latest thinking...
Biology Products: